115 related articles for article (PubMed ID: 9597004)
1. An active efflux system for heavy metals in cisplatin-resistant human KB carcinoma cells.
Chen ZS; Mutoh M; Sumizawa T; Furukawa T; Haraguchi M; Tani A; Saijo N; Kondo T; Akiyama S
Exp Cell Res; 1998 May; 240(2):312-20. PubMed ID: 9597004
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the ATP-dependent LTC4 transporter in cisplatin-resistant human KB cells.
Chuman Y; Chen ZS; Sumizawa T; Furukawa T; Haraguchi M; Takebayashi Y; Niwa K; Yamada K; Aikou T; Akiyama S
Biochem Biophys Res Commun; 1996 Sep; 226(1):158-65. PubMed ID: 8806607
[TBL] [Abstract][Full Text] [Related]
3. Reversal of heavy metal resistance in multidrug-resistant human KB carcinoma cells.
Chen ZS; Mutoh M; Sumizawa T; Furukawa T; Haraguchi M; Tani A; Akiyama S
Biochem Biophys Res Commun; 1997 Jul; 236(3):586-90. PubMed ID: 9245693
[TBL] [Abstract][Full Text] [Related]
4. ATP-Dependent efflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and its inhibition by PAK-104P.
Chen ZS; Furukawa T; Sumizawa T; Ono K; Ueda K; Seto K; Akiyama SI
Mol Pharmacol; 1999 May; 55(5):921-8. PubMed ID: 10220571
[TBL] [Abstract][Full Text] [Related]
5. An enhanced active efflux of CPT-11 and SN-38 in cisplatin-resistant human KB carcinoma cells.
Chen ZS; Sumizawa T; Furukawa T; Ono K; Tani A; Komatsu M; Akiyama S
Cancer Lett; 1999 Apr; 138(1-2):13-22. PubMed ID: 10378768
[TBL] [Abstract][Full Text] [Related]
6. Differences in substrate specificity among glutathione conjugates (GS-X) pump family members: comparison between multidrug resistance-associated protein and a novel transporter expressed on a cisplatin-resistant cell line (KCP-4).
Ueda K; Suzuki H; Akiyama S; Sugiyama Y
Jpn J Cancer Res; 1999 Apr; 90(4):439-47. PubMed ID: 10363583
[TBL] [Abstract][Full Text] [Related]
7. Reversal of MRP-mediated vincristine resistance in KB cells by buthionine sulfoximine in combination with PAK-104P.
Chuman Y; Chen ZS; Seto K; Sumizawa T; Furukawa T; Tani A; Haraguchi M; Niwa K; Yamada K; Aikou T; Akiyama S
Cancer Lett; 1998 Jul; 129(1):69-76. PubMed ID: 9714337
[TBL] [Abstract][Full Text] [Related]
8. Coordinated induction of MRP/GS-X pump and gamma-glutamylcysteine synthetase by heavy metals in human leukemia cells.
Ishikawa T; Bao JJ; Yamane Y; Akimaru K; Frindrich K; Wright CD; Kuo MT
J Biol Chem; 1996 Jun; 271(25):14981-8. PubMed ID: 8663001
[TBL] [Abstract][Full Text] [Related]
9. Factors involved in the cisplatin resistance of KCP‑4 human epidermoid carcinoma cells.
Oiso S; Takayama Y; Nakazaki R; Matsunaga N; Motooka C; Yamamura A; Ikeda R; Nakamura K; Takeda Y; Kariyazono H
Oncol Rep; 2014 Feb; 31(2):719-26. PubMed ID: 24317338
[TBL] [Abstract][Full Text] [Related]
10. [ATP-dependent glutathione conjugate export pump].
Furukawa T; Chen ZS; Akiyama S
Nihon Rinsho; 1997 May; 55(5):1083-90. PubMed ID: 9155157
[TBL] [Abstract][Full Text] [Related]
11. Expression of gamma-glutamylcysteine synthetase (gamma-GCS) and multidrug resistance-associated protein (MRP), but not human canalicular multispecific organic anion transporter (cMOAT), genes correlates with exposure of human lung cancers to platinum drugs.
Oguri T; Fujiwara Y; Isobe T; Katoh O; Watanabe H; Yamakido M
Br J Cancer; 1998 Apr; 77(7):1089-96. PubMed ID: 9569044
[TBL] [Abstract][Full Text] [Related]
12. Adenosine triphosphate-dependent transport of leukotriene C4 by membrane vesicles prepared from cisplatin-resistant human epidermoid carcinoma tumor cells.
Fujii R; Mutoh M; Sumizawa T; Chen ZS; Yoshimura A; Akiyama S
J Natl Cancer Inst; 1994 Dec; 86(23):1781-4. PubMed ID: 7966417
[TBL] [Abstract][Full Text] [Related]
13. Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter.
Chen ZS; Kawabe T; Ono M; Aoki S; Sumizawa T; Furukawa T; Uchiumi T; Wada M; Kuwano M; Akiyama SI
Mol Pharmacol; 1999 Dec; 56(6):1219-28. PubMed ID: 10570049
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of glucuronosyl etoposide transport by glutathione in multidrug resistance-associated protein-overexpressing cells.
Sakamoto H; Hara H; Hirano K; Adachi T
Cancer Lett; 1999 Jan; 135(1):113-9. PubMed ID: 10077229
[TBL] [Abstract][Full Text] [Related]
15. Active efflux system for cisplatin in cisplatin-resistant human KB cells.
Fujii R; Mutoh M; Niwa K; Yamada K; Aikou T; Nakagawa M; Kuwano M; Akiyama S
Jpn J Cancer Res; 1994 Apr; 85(4):426-33. PubMed ID: 8200854
[TBL] [Abstract][Full Text] [Related]
16. Transient induction of the MRP/GS-X pump and gamma-glutamylcysteine synthetase by 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3- nitrosourea in human glioma cells.
Gomi A; Shinoda S; Masuzawa T; Ishikawa T; Kuo MT
Cancer Res; 1997 Dec; 57(23):5292-9. PubMed ID: 9393752
[TBL] [Abstract][Full Text] [Related]
17. Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR?
Borst P; Kool M; Evers R
Semin Cancer Biol; 1997 Jun; 8(3):205-13. PubMed ID: 9441949
[TBL] [Abstract][Full Text] [Related]
18. Enhanced nucleotide excision repair in cisplatin resistant human KB carcinoma cells.
Mukai M; Kanzaki A; Chen ZS; Miyashita H; Sumizawa T; Furukawa T; Haraguchi M; Takebayashi Y; Takamatsu H; Akiyama S
Oncol Rep; 2002; 9(4):839-44. PubMed ID: 12066219
[TBL] [Abstract][Full Text] [Related]
19. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation.
Taniguchi K; Wada M; Kohno K; Nakamura T; Kawabe T; Kawakami M; Kagotani K; Okumura K; Akiyama S; Kuwano M
Cancer Res; 1996 Sep; 56(18):4124-9. PubMed ID: 8797578
[TBL] [Abstract][Full Text] [Related]
20. Involvement of NF-κB activation in the cisplatin resistance of human epidermoid carcinoma KCP-4 cells.
Oiso S; Ikeda R; Nakamura K; Takeda Y; Akiyama S; Kariyazono H
Oncol Rep; 2012 Jul; 28(1):27-32. PubMed ID: 22562377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
